Why the study?
Does the development of de novo donor-specific antibodies to DQ antigens increase the risk of death or graft dysfunction in heart transplant recipients compared to non-DQ antibodies or no antibodies?
Does the development of de novo donor-specific antibodies to DQ antigens increase the risk of death or graft dysfunction in heart transplant recipients compared to non-DQ antibodies or no antibodies?
De novo donor-specific antibodies to DQ antigens following heart transplantation are associated with a significantly increased risk of death and graft dysfunction compared to non-DQ antibodies.
Answers are grounded in this paper and cite their sources.
dnDSA to DQ may worsen post-HTx outcomes; leaves open whether antigen-specific monitoring alters management.
BACKGROUND: Antibody-mediated rejection (AMR) resulting from de novo donor-specific antibodies (dnDSA) leads to adverse outcomes following heart transplantation (HTx). It remains unclear what role dnDSA to specific HLA antigens play in adverse outcomes. This study compares outcomes in patients developing dnDSA to DQ antigens with those developing non-DQ dnDSA and those free from dnDSA. METHODS: The present study was a single-center, retrospective analysis of 122 consecutive HTx recipients. The primary outcome was a composite of death or graft dysfunction. RESULTS: After 3.3 years of follow-up, 31 (28%) patients developed dnDSA. Mean time to dnDSA was 539 days. Of 31 patients, 19 developed DQ antibodies and 12 developed non-DQ antibodies. Compared to non-DQ dnDSA, DQ antibodies presented with higher MFI values (P=.001) were more likely persistent (P=.001) and appeared later post-HTx (654 vs 359 days, P=.035). In a multivariable analysis, DQ dnDSA was associated with increased risk of the primary endpoint (HR 6.15, 95% CI 2.57-14.75, P=.001), whereas no increased risk was seen with non-DQ dnDSA (P=.749). CONCLUSIONS: dnDSA to DQ antigens following HTx are associated with increased risk of death and graft dysfunction.
No takes yet. Share an insight, caveat, or question.
Cole et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: